000			02044 a2200481 4500
005			20250513085432.0
264		0	_c19960404
008			199604s 0 0 eng d
022			_a0007-1188
024	7		_a10.1111/j.1476-5381.1995.tb17222.x _2doi
040			_aNLM _beng _cNLM
100	1		_aSmart, D
245	0	0	_aDesensitization of the mu-opioid activation of phospholipase C in SH-SY5Y cells: the role of protein kinases C and A and Ca(2+)-activated K+ currents. _h[electronic resource]
260			_bBritish journal of pharmacology _cNov 1995
300			_a2655-60 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester _xpharmacology
650	0	4	_aAnalgesics, Opioid _xpharmacology
650	0	4	_aCalcium _xphysiology
650	0	4	_aCalcium Channel Agonists _xpharmacology
650	0	4	_aCalcium Channel Blockers _xpharmacology
650	0	4	_aCyclic AMP-Dependent Protein Kinases _xantagonists & inhibitors
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFentanyl _xpharmacology
650	0	4	_aHumans
650	0	4	_aIndoles _xpharmacology
650	0	4	_aInositol 1,4,5-Trisphosphate _xmetabolism
650	0	4	_aIsoquinolines _xpharmacology
650	0	4	_aNarcotics _xpharmacology
650	0	4	_aNeuroblastoma _xenzymology
650	0	4	_aNifedipine _xpharmacology
650	0	4	_aPotassium Channels _xdrug effects
650	0	4	_aProtein Kinase C _xantagonists & inhibitors
650	0	4	_aReceptors, Opioid, mu _xdrug effects
650	0	4	_aSensitivity and Specificity
650	0	4	_aSulfonamides
650	0	4	_aTumor Cells, Cultured _xdrug effects
650	0	4	_aType C Phospholipases _xmetabolism
700	1		_aLambert, D G
773	0		_tBritish journal of pharmacology _gvol. 116 _gno. 6 _gp. 2655-60
856	4	0	_uhttps://doi.org/10.1111/j.1476-5381.1995.tb17222.x _zAvailable from publisher's website
999			_c8590034 _d8590034